Global Interventional Neurology Market-By Product and Region-Prediction 2022-2030 Year

SDKI Inc. published a new report on the global interventional neurology market on November 02, 2021. This study includes the statistical and analytical approaches needed to grow the interventional neurology market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-58927

The interventional neurology market is estimated to reach US $ 4.79 billion by 2030 from a market value of US $ 2.69 billion in 2022 and is expected to grow at a CAGR of 8.60% during the 2022-2030 forecast period.

Interventional neurology is a new procedure adopted for the non-surgical treatment of neurological disorders. .. Interventional neurology has a wide range of uses in the diagnosis of the peripheral and nervous systems. Large target patient population, continued product development and commercialization, and favorable medical reimbursement are key factors driving the growth of the interventional neurology market. According to the World Health Organization, neuropathy accounts for 6.3% of the world's disease burden. Also, according to the European Academy of Neurology, about 220.7 million people in Europe will suffer from neurological disorders in 2018.

In addition, the expansion of healthcare infrastructure across emerging markets and the growing demand for effective neurovascular devices are further contributing to the growth of the interventional neurology market. In addition, increased research activity in the field of neurovascular therapy and increased demand for minimally invasive neurosurgery are expected to create significant growth opportunities for the interventional neurology market during the forecast period. According to the Indian Brand Equity Foundation, the government is spending about US $ 1.14 billion on treatment as cases of neuropathy increase in 2018, providing awareness of central nervous system disorders. In the United States, total mental health spending accounts for 2.4% of the government's total medical spending. In addition, lower product costs due to stronger distribution networks and localized manufacturing could boost the growth of the interventional neurology market during the forecast period.

However, strict regulations and the lack of skilled neurosurgeons can impede the growth of the interventional neurology market during the 2022-2030 forecast period.

Report sample URL
https://www.sdki.jp/sample-request-58927

Interventional Neurology Market Segment

The interventional neurology market is by product (aneurysm coil and embolization device, cerebral balloon angioplasty and stent placement system, support device, nerve thrombosection device) by disease pathology (ischemic). Stroke, cerebral aneurysms, arteriovenous malformations and fistulas, and other pathologies), and by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.